These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24822087)

  • 41. Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype.
    de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; Beaure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC;
    Front Neurol; 2020; 11():603. PubMed ID: 32733359
    [No Abstract]   [Full Text] [Related]  

  • 42. Self-injurious, aggressive and destructive behaviour in children with severe intellectual disability: Prevalence, service need and service receipt in the UK.
    Ruddick L; Davies L; Bacarese-Hamilton M; Oliver C
    Res Dev Disabil; 2015; 45-46():307-15. PubMed ID: 26296078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Actigraph-Measured Movement Correlates of Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Young People with Tuberous Sclerosis Complex (TSC) with and without Intellectual Disability and Autism Spectrum Disorder (ASD).
    Earnest T; Shephard E; Tye C; McEwen F; Woodhouse E; Liang H; Sheerin F; Bolton PF
    Brain Sci; 2020 Jul; 10(8):. PubMed ID: 32731531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioral Phenotype and Autism Spectrum Disorders in Cornelia de Lange Syndrome.
    Parisi L; Di Filippo T; Roccella M
    Ment Illn; 2015 Sep; 7(2):5988. PubMed ID: 26605036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistence and predictors of self-injurious behaviour in autism: a ten-year prospective cohort study.
    Laverty C; Oliver C; Moss J; Nelson L; Richards C
    Mol Autism; 2020; 11(1):8. PubMed ID: 31988707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.
    Müller AR; den Hollander B; van de Ven PM; Roes KCB; Geertjens L; Bruining H; van Karnebeek CDM; Jansen FE; de Wit MCY; Ten Hoopen LW; Rietman AB; Dierckx B; Wijburg FA; Boot E; Brands MMG; van Eeghen AM
    BMC Psychiatry; 2024 Jan; 24(1):23. PubMed ID: 38177999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prevalence of aggression in genetic syndromes: a review.
    Powis L; Oliver C
    Res Dev Disabil; 2014 May; 35(5):1051-71. PubMed ID: 24594523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review of the behaviours associated with depression in people with severe-profound intellectual disability.
    Eaton C; Tarver J; Shirazi A; Pearson E; Walker L; Bird M; Oliver C; Waite J
    J Intellect Disabil Res; 2021 Mar; 65(3):211-229. PubMed ID: 33426741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Problem behaviour in adolescent boys with fragile X syndrome: relative prevalence, frequency and severity.
    Hall SS; Barnett RP; Hustyi KM
    J Intellect Disabil Res; 2016 Dec; 60(12):1189-1199. PubMed ID: 27730710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deconstructing the repetitive behaviour phenotype in autism spectrum disorder through a large population-based analysis.
    Uljarević M; Cooper MN; Bebbington K; Glasson EJ; Maybery MT; Varcin K; Alvares GA; Wray J; Leekam SR; Whitehouse AJO
    J Child Psychol Psychiatry; 2020 Sep; 61(9):1030-1042. PubMed ID: 32037582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders.
    Valdovinos MG; Epperson C; Johnson C
    Int Rev Neurobiol; 2023; 173():43-65. PubMed ID: 37993179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic modifiers in rare disorders: the case of fragile X syndrome.
    Crawford H; Scerif G; Wilde L; Beggs A; Stockton J; Sandhu P; Shelley L; Oliver C; McCleery J
    Eur J Hum Genet; 2021 Jan; 29(1):173-183. PubMed ID: 32862204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-injurious behaviours in children and adults with autism spectrum disorder (ASD).
    Gulsrud A; Lin CE; Park MN; Hellemann G; McCracken J
    J Intellect Disabil Res; 2018 Dec; 62(12):1030-1042. PubMed ID: 29696700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-injurious behaviour in Cornelia de Lange syndrome: 1. Prevalence and phenomenology.
    Oliver C; Sloneem J; Hall S; Arron K
    J Intellect Disabil Res; 2009 Jul; 53(7):575-89. PubMed ID: 19522788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oscillatory neural network alterations in young people with tuberous sclerosis complex and associations with co-occurring symptoms of autism spectrum disorder and attention-deficit/hyperactivity disorder.
    Shephard E; McEwen FS; Earnest T; Friedrich N; Mörtl I; Liang H; Woodhouse E; ; Tye C; Bolton PF
    Cortex; 2022 Jan; 146():50-65. PubMed ID: 34839218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. L-acetylcarnitine for treating fragile X syndrome.
    Rueda JR; Guillén V; Ballesteros J; Tejada MI; Solà I
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010012. PubMed ID: 25985235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioural and cognitive-behavioural interventions for outwardly directed aggressive behaviour in people with intellectual disabilities.
    Prior D; Win S; Hassiotis A; Hall I; Martiello MA; Ali AK
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD003406. PubMed ID: 36745863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with autism spectrum disorder in children with tuberous sclerosis complex: a systematic review and meta-analysis.
    Mitchell RA; Barton SM; Harvey AS; Ure AM; Williams K
    Dev Med Child Neurol; 2021 Jul; 63(7):791-801. PubMed ID: 33432576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Divergent presentation of anxiety in high-risk groups within the intellectual disability population.
    Groves L; Moss J; Oliver C; Royston R; Waite J; Crawford H
    J Neurodev Disord; 2022 Oct; 14(1):54. PubMed ID: 36199025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding speech and language in tuberous sclerosis complex.
    Gipson TT; Oller DK; Messinger DS; Perry LK
    Front Hum Neurosci; 2023; 17():1149071. PubMed ID: 37323931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.